-
Article - 2 Minute Read
UPMC’s Pioneering Thyroid Cancer Test Is Now Covered by Medicare
The ThyroSeq Genomic Classifier was approved for coverage by Medicare, the first step to making it available to more than 50 million people nationwide. Read More
Categorized as: Cancer Care, UPMC Next